title: Thrombin-induced MCP-1 expression involves activation of the p22phox-containing NADPH oxidase in human vascular smooth muscle cells.
abstract: Activation of vascular smooth muscle cells (VMSC) by thrombin induces the expression of the chemokine, monocyte chemoattractant protein-1 (MCP-1). We investigated in cultured human and rat VSMC whether reactive oxygen species (ROS) derived from the vascular NADPH oxidase contribute to this effect. Exposure of cultured VSMC to thrombin rapidly increased ROS formation, phosphorylation of p38 MAP kinase as well as the expression of MCP-1. Specific inhibition of the p22phox subunit of the vascular NADPH oxidase using either p22phox neutralizing antibody or p22phox antisense oligonucleotides attenuated thrombin-induced ROS generation. Furthermore, thrombin-induced p38 MAP kinase activation as well as MCP-1 expression were impaired by antioxidants as well as by p22phox antisense oligonucleotides. Inhibition of p38 MAP kinase diminished the thrombin-induced expression of MCP-1.
  
  
  CONCLUSIONS
  Thrombin, by activating a p22phox-containing NADPH oxidase, elicits ROS generation and activation of p38 MAP kinase in VSMC. The subsequent induction of MCP-1 expression highligts the crucial role of the p22phox-containing NADPH oxidase in thrombin-induced signal transduction in VSMC.
authors: Institut für Kardiovaskuläre Physiologie, Klinikum der JW Goethe-Universität, Frankfurt/Main, Germany. R.Brandes@em.uni-frankfurt.de
authors: R P
authors: RP
authors: Brandes
authors: C
authors: C
authors: Viedt
authors: K
authors: K
authors: Nguyen
authors: S
authors: S
authors: Beer
authors: J
authors: J
authors: Kreuzer
authors: R
authors: R
authors: Busse
authors: A
authors: A
authors: Görlach
mesh_terms: D000818:Animals; D001011:Aorta / Q000166:cytology; D018929:Cell Culture Techniques; D018932:Chemokine CCL2 / Q000378:metabolism*; D004305:Dose-Response Relationship, Drug; D004789:Enzyme Activation / Q000187:drug effects; D006801:Humans; D007700:Kinetics; D020935:MAP Kinase Signaling System / Q000187:drug effects; D008297:Male; D026901:Membrane Transport Proteins; D009131:Muscle, Smooth, Vascular / Q000166:cytology / Q000187:drug effects* / Q000201:enzymology / Q000378:metabolism; D009252:NADPH Dehydrogenase; D019255:NADPH Oxidases / Q000737:chemistry / Q000378:metabolism* / Q000494:pharmacology; D010750:Phosphoproteins; D051381:Rats; D017208:Rats, Wistar; D017382:Reactive Oxygen Species / Q000378:metabolism; D013917:Thrombin / Q000494:pharmacology* / Q000502:physiology
chemical_list: D018932:Chemokine CCL2; D026901:Membrane Transport Proteins; D010750:Phosphoproteins; D017382:Reactive Oxygen Species; D019255:NADPH Oxidases; C086986:CYBA protein, human; D009252:NADPH Dehydrogenase; D013917:Thrombin